Galapagos down on red AEX | Financial

At around 9.30 am, the AEX index was 0.4% lower at 561.8 points. The AMX was up 0.4% at 839.4 points. The price signs in London (-0.5%), Paris (-0.3%) and Frankfurt (-0.3) turned red.

Elsewhere, the stock markets were positive. The Japanese Nikkei index closed 0.3% higher this morning. The American stock exchanges is expected to open more than 0.2% in green this afternoon after a 0.3% to 0.5% higher close on Tuesday evening. Secretary of the Treasury Steven Mnuchin and Nancy Pelosi, the Democratic chair of the US House of Representatives, missed Tuesday’s deadline for drafting a new bailout package for victims of the US corona crisis. But they did come closer to an agreement and are expected to continue speaking today.

Randstad shot up 7.1% in the AEX. The broadcaster showed further recovery in the third quarter, after the group was previously hit hard by the corona crisis. Randstad continued in the period significantly lower results in the books than a year ago. But the numbers were generally better than analysts expected.

Insurer Aegon climbed 1.3%. The financial values ​​also lay ABN Amro (+ 1.2%) positive.

Galapagos (-6%) was the largest drop among the main funds. Goldman Sachs provided a sales recommendation for the biotechnology group. The investment bank also lowered its target price for the Galapagos share from € 108 to € 87.

AkzoNobel (-0.9%) for the past quarter a significantly higher profit, but apparently investors had expected a little more. The paint manufacturer mainly benefited from cost savings in the past quarter. AkzoNobel will buy back € 300 million in its own shares and pay an interim dividend.

Adyen (-0.2%) reported having found a successor for technology director and co-founder Arnout Schuijff. His role in the payment processor will be taken over by Alexander Matthey starting the new year. He has been working for Adyen for over five years.

In de AMX was Pharming in demand with a price jump of 5.8%. The biotech company announced that it had received orphan drug status from the European Commission for his medicine leniolisib. This is a drug for the treatment of APDS, a rare and serious disease affecting the immune system.

Logistics real estate fund WDP (+ 3.7%) tightened up the profit forecast for the whole year and is now counting on it earnings per share of € 1. Previously, a bandwidth of € 0.95 to € 1.00 was assumed.

Fugro 4.9% was reset. The soil researcher won more than 22% on Tuesday after the announcement of a share issue.

Smallcapfonds Nedap (+ 3.6%) already released a quarterly update on Tuesday after the closing bell. The technology company saw sales in the third quarter fall by 5 percent compared to a year ago.

Also the locally noted maker of meat and fish processing machines Marel (+ 1.1%) came after the closing bell with numbers. The company posted less turnover and profit last quarter.

Would you like to receive the DFT Newsletter automatically by email every morning from now on? Then you can sign up here for free.

–